# An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol

> **NCT04788290** · — · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 3907 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT04788290
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-06
- **Primary completion:** 2020-07-13
- **Final completion:** 2020-07-13
- **Target enrollment:** 3907 (ACTUAL)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04788290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04788290, "An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04788290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*